United States Department of Veterans Affairs
Hepatitis C

Table 6. HCV PI (BOC or TVR): RGT criteria and futility rules

Home > Providers' Home > Clinical Care > Guidelines > 2012 Recommendations > Table 6

for Health Care Providers

Table 6. HCV PI (BOC or TVR): RGT criteria and futility rules

Update on the Management and Treatment of Hepatitis C Virus Infection

Hepatitis C Resource Center Program
National Hepatitis C Program Office

July 2012

Table 6. HCV PI (BOC or TVR): RGT criteria and futility rules (34, 35)
BOC-PegIFN/RBVTVR-PegIFN/RBV
HCV, hepatitis C virus; PegIFN, peginterferon; PI, protease inhibitor; RBV, ribavirin; RGT, response-guided therapy; TVR, telaprevir.
Candidates for RGT Noncirrhotics:
Treatment-naive: 28 weeks
Prior relapser/partial responder: 36 weeks 		Noncirrhotics:
Treatment-naive: 24 weeks
Prior relapser: 24 weeks
Criteria for RGT HCV RNA undetectable (<10-15 IU/ml) weeks 8-24 HCV RNA undetectable (<10-15 IU/ml) weeks 4 and 12
Futility rules (stop all treatment if any of the following occur)

Week 12: HCV RNA ≥100 IU/ml

Or

Week 24: HCV RNA detectable

Or

HCV RNA rebounds at any timepoint (≥1 log10increase from the nadir HCV RNA)

Week 4 or 12: HCV RNA >1,000 IU/ml

Or

Week 24: HCV RNA detectable

Or

HCV RNA rebounds at any timepoint (≥1 log10 increase from the nadir HCV RNA)